Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts.

Mondoulet L, Kalach N, Dhelft V, Larcher T, Delayre-Orthez C, Benhamou PH, Spergel J, Sampson HA, Dupont C.

Clin Exp Allergy. 2017 Dec;47(12):1640-1647. doi: 10.1111/cea.13037. Epub 2017 Oct 20.

PMID:
28960628
2.

Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice.

Mondoulet L, Dioszeghy V, Larcher T, Ligouis M, Dhelft V, Puteaux E, Cherel Y, Letourneur F, Dupont C, Benhamou PH.

PLoS One. 2012;7(2):e31967. doi: 10.1371/journal.pone.0031967. Epub 2012 Feb 21.

3.

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Plaquet C, Dupont C, Benhamou PH.

J Allergy Clin Immunol. 2015 Jun;135(6):1546-57.e4. doi: 10.1016/j.jaci.2014.11.028. Epub 2015 Jan 9.

PMID:
25583102
4.

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Dupont C, Benhamou PH.

Clin Exp Allergy. 2014 Jun;44(6):867-81. doi: 10.1111/cea.12312.

5.

Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.

Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou PH.

Clin Exp Allergy. 2010 Apr;40(4):659-67. doi: 10.1111/j.1365-2222.2009.03430.x. Epub 2009 Dec 10.

PMID:
20002446
6.

Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.

Jones SM, Sicherer SH, Burks AW, Leung DY, Lindblad RW, Dawson P, Henning AK, Berin MC, Chiang D, Vickery BP, Pesek RD, Cho CB, Davidson WF, Plaut M, Sampson HA, Wood RA; Consortium of Food Allergy Research.

J Allergy Clin Immunol. 2017 Apr;139(4):1242-1252.e9. doi: 10.1016/j.jaci.2016.08.017. Epub 2016 Oct 26.

PMID:
28091362
7.

Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

Srivastava KD, Siefert A, Fahmy TM, Caplan MJ, Li XM, Sampson HA.

J Allergy Clin Immunol. 2016 Aug;138(2):536-543.e4. doi: 10.1016/j.jaci.2016.01.047. Epub 2016 Apr 26.

PMID:
27130858
8.

Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA, Berin MC.

J Allergy Clin Immunol. 2017 Jan;139(1):189-201.e4. doi: 10.1016/j.jaci.2016.03.057. Epub 2016 Jun 11.

9.

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.

Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC, Cheema AS, Leonard SA, Pongracic JA, Sauvage-Delebarre C, Assa'ad AH, de Blay F, Bird JA, Tilles SA, Boralevi F, Bourrier T, Hébert J, Green TD, Gerth van Wijk R, Knulst AC, Kanny G, Schneider LC, Kowalski ML, Dupont C.

JAMA. 2017 Nov 14;318(18):1798-1809. doi: 10.1001/jama.2017.16591.

10.

Current Trend in Immunotherapy for Peanut Allergy.

Joo Chan C, Richardo T, Lim RLH.

Int Rev Immunol. 2018;37(6):279-290. doi: 10.1080/08830185.2018.1509967. Epub 2019 Jan 13. Review.

PMID:
30638084
11.

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.

Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Letourneur F, Dupont C, Benhamou PH.

Clin Transl Allergy. 2012 Nov 12;2(1):22. doi: 10.1186/2045-7022-2-22.

12.

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, Wood RA.

J Allergy Clin Immunol. 2015 May;135(5):1275-82.e1-6. doi: 10.1016/j.jaci.2014.11.005. Epub 2014 Dec 18.

13.

A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT.

J Allergy Clin Immunol. 2013 Dec;132(6):1368-74. doi: 10.1016/j.jaci.2013.09.046. Epub 2013 Oct 28.

14.

Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy.

Echeverría-Zudaire LÁ, Fernández-Fernández S, Rayo-Fernández A, Muñóz-Archidona C, Checa-Rodriguez R.

Allergol Immunopathol (Madr). 2016 Nov - Dec;44(6):531-536. doi: 10.1016/j.aller.2016.05.002. Epub 2016 Aug 31.

PMID:
27592279
15.

Component-Resolved Diagnosis of Peanut Allergy and Its Possible Origins of Sensitization in China.

Ma S, Nie L, Li H, Wang R, Yin J.

Int Arch Allergy Immunol. 2016;169(4):241-8. doi: 10.1159/000446156. Epub 2016 May 31.

16.

Efficacy of Epicutaneous Immunotherapy in Children with Milk-Induced Eosinophilic Esophagitis.

Spergel JM, Elci OU, Muir AB, Liacouras CA, Wilkins BJ, Burke D, Lewis MO, Brown-Whitehorn T, Cianferoni A.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30524-5. doi: 10.1016/j.cgh.2019.05.014. [Epub ahead of print]

PMID:
31100455
17.

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.

Dioszeghy V, Mondoulet L, Puteaux E, Dhelft V, Ligouis M, Plaquet C, Dupont C, Benhamou PH.

Cell Mol Immunol. 2017 Sep;14(9):770-782. doi: 10.1038/cmi.2016.14. Epub 2016 Apr 11.

18.

Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.

Michaud E, Evrard B, Pereira B, Rochette E, Bernard L, Rouzaire PO, Gourdon-Dubois N, Merlin E, Fauquert JL.

Trials. 2015 Apr 29;16:197. doi: 10.1186/s13063-015-0717-y.

19.

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice.

Mondoulet L, Dioszeghy V, Busato F, Plaquet C, Dhelft V, Bethune K, Leclere L, Daviaud C, Ligouis M, Sampson H, Dupont C, Tost J.

Allergy. 2019 Jan;74(1):152-164. doi: 10.1111/all.13479. Epub 2018 Oct 8.

20.

Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.

Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA; Consortium of Food Allergy Research (CoFAR).

J Allergy Clin Immunol. 2013 Jan;131(1):119-27.e1-7. doi: 10.1016/j.jaci.2012.11.011.

Supplemental Content

Support Center